Companies

Aureka Biotechnologies

aurekabio.com

A tech-bio startup using generative AI and high-throughput biology to discover antibody therapeutics.

Employees11-50
Funding~$100M
1 active role
Healthcare AIAI ApplicationAPI / PlatformSeries A$50M-$200M

About

Aureka Biotechnologies is a tech-bio startup that develops a generative AI platform, AuraIDE, to discover and develop antibody therapeutics. The company integrates high-throughput autonomous evolution and single-cell functional screening to design differentiated candidates for cardiometabolic and inflammatory diseases. It operates through a BD/NewCo collaboration model with multinational pharmaceutical companies.

Active Roles

1

Key Investors

HongShan, MPCi (Matrix Partners China), BioTrack Capital, 5Y Capital, Qiming Venture Partners, NRL Capital, K2VC, Newlife Capital